AnaptysBio Inc (ANAB)
23.77
-0.48
(-1.98%)
USD |
NASDAQ |
Jun 14, 16:00
23.66
-0.11
(-0.46%)
After-Hours: 20:00
AnaptysBio Stock Buybacks (Quarterly): -0.811M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.811M |
December 31, 2023 | -0.264M |
September 30, 2023 | -0.16M |
June 30, 2023 | 11.69M |
March 31, 2023 | 36.26M |
December 31, 2022 | -3.419M |
September 30, 2022 | -2.699M |
June 30, 2022 | -0.865M |
March 31, 2022 | -4.844M |
December 31, 2021 | -1.591M |
September 30, 2021 | -0.241M |
June 30, 2021 | -0.554M |
March 31, 2021 | -0.167M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 |
Date | Value |
---|---|
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | -227.48M |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -212.32M |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | -80.21M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.001M |
December 31, 2015 | 0.148M |
September 30, 2015 | -0.079M |
June 30, 2015 | -0.026M |
March 31, 2015 | -0.043M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-4.844M
Minimum
Mar 2022
36.26M
Maximum
Mar 2023
2.488M
Average
-0.554M
Median
Jun 2021
Stock Buybacks (Quarterly) Benchmarks
XOMA Corp | 0.013M |
Fate Therapeutics Inc | -75.19M |
Ocular Therapeutix Inc | -316.35M |
Apellis Pharmaceuticals Inc | -98.76M |
Sutro Biopharma Inc | 0.00 |